Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug may cool hot flashes for breast cancer patients

NCT ID NCT06917313

Recruiting now Symptom relief Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 34 times

Summary

This study tests a daily pill called fezolinetant to see if it can reduce hot flashes in women who have had early-stage breast cancer and are taking hormone therapy. About 92 women will be randomly assigned to receive either the drug or a placebo. The main goal is to measure how much the frequency of hot flashes decreases after 12 weeks of treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Ohio State University Comprehensive Cancer Center

    NOT_YET_RECRUITING

    Columbus, Ohio, 43201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Yale University

    RECRUITING

    New Haven, Connecticut, 06511, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)